Clinical course and symptomatic prediagnostic period of patients with wegener's granulomatosis and microscopic polyangiitis

References

• Andrassy K, Küster S, Waldherr R, Ritz E. Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. Nephron 1991; 59: 206–212
   PubMed Web of Science ®Google Scholar
• Brass H., Schleiffer T. Renal involvement of systemic diseases. Nieren- und Hochdruckkrankheiten 1989; 18: 40–46
   Google Scholar
• Walton EW. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1958; 1: 265–270
   PubMedGoogle Scholar
• Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Clinical review. Ann Mt Med 1983; 98: 76–85
   Web of Science ®Google Scholar
• Van der Woude FJ, Rasmussen N, Lobatto S. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425–429
   PubMed Web of Science ®Google Scholar
• Leavitt RY, Fauci AS, Bloch DA. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 8: 1101–1107
   Google Scholar
• Jenrette JC, Falk RJ, Andrassy K. Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187–192
   PubMedGoogle Scholar
• Marin J, Schleiffer T, Lampante L, de Leon F, de lvlas R. Rare manifestation of Wegener's granulomatosis on the pars prostatica urethrae and the upper respiratory tract. Akt Urol (German) 1996; 27: 235–237
   Web of Science ®Google Scholar
• Briedigkeit L, Göbel U, Schneider W, Kettritz R, Natusch R. Wegener's granulomatosis. A retrospective multicenter study. Nieren- und Hochdruckkrankheiten 1992; 21: 233–242
   Google Scholar
• Gans ROB, Kuizinga MC, Goldsdnmeding R. Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantiibodies. Nephron 1993; 64: 182–188
   PubMed Web of Science ®Google Scholar
• Hoffman GS, Kerr GS, Leavitt RY. Wegener granulomatosis: an analysis of 158 patients. Ann Int Med 1992; 116: 488–498
   PubMed Web of Science ®Google Scholar
• Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis classification criteria cohort. Am J Med 1996; 101: 129–134
   PubMed Web of Science ®Google Scholar
• Case records of the Massachusetts General Hospital. Case 25–1989. N Engl J Med 1989; 320: 1677–1686
   PubMedGoogle Scholar
• Wegener F. Über generalisierte, septisehe Gefässerkrankunge n. Verh Dtsch Path Ges 1936; 29: 202–210
   Google Scholar
• Wegener F. Über eme eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitr Path Anat 1939; 102: 36–68
   Google Scholar
• Wegener F. Die pneumogene allgemeine Granulomatose—sog. Wegener'sche granulomatose. Lehrbuch der speziellen pathologischen Ancrtomie von Kaufmann E, Ergänzungsband I 1/1, M Staemmler. W de Gruyter, Berlin 1961; 225–299
   Google Scholar
• Gross WL, Lüdemann G, Kiefer G, Lehmann H. Anticytoplasmic antibodies in Wegener's granulomatosis (letter). Lancet 1986; 1: 806
   PubMed Web of Science ®Google Scholar
• de Groot K, Reinhold-Keller E, Tatsis E. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis: Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 1996; 39: 2052–2061
   PubMed Web of Science ®Google Scholar
• Fienberg R. The protracted superficial phenomenon in pathergic (Wegener's) granulomatosis. Hum Pathol 1981; 12: 458–467
   PubMed Web of Science ®Google Scholar
• Adam O, Wiesinger H. Clinical course of untreated Wegener's granulomatosis. Klin Wochenschr (German) 1988; 66: 181–186
   PubMedGoogle Scholar
• Woodworth TG, Abuelo JG, Austin HA, Esparza A. Severe glomerulonephritis with late emergence of classic Wegener's granulomatosis. Report of 4 cases and review of the literature. Medicine 1987; 66: 181–191
   PubMed Web of Science ®Google Scholar
• Wegener F. About the so-called Wegener's granulomatosis with special reference to the generalized vascular lesions. Morgagni 1968; 1: 5–23
   Google Scholar
• Yildizer K, Paydas S, Sevin E, Sagliker Y. Wegener's granulomatosis complicated by pericardial tamponade and renal failure. Nephron 1996; 72: 339–340
   PubMed Web of Science ®Google Scholar
• Schiavone WA, Ahmad M, Odcner SA. Unusual cardiac complications of Wegener's granulomatosis. Chest 1985; 88: 745–748
   PubMed Web of Science ®Google Scholar
• Gerbradtt DD, Savage RW, Scharff N. Reversible vavulitis in Wegener's granulomatosis. Chest 1987; 92: 182–183
   PubMed Web of Science ®Google Scholar
• Rivera M, Gonzalez C, Gonzalo A, Quereda C, Fogue L, Ortuno J. Vasculitis associated with non-Hodgkin's lymphoma. Nephron 1993; 65: 167–168
   PubMed Web of Science ®Google Scholar
• Largiader A. Wegenner'sche Granulomatose. Schweiz Med Wschr 1964; 94: 1000–1003
   PubMedGoogle Scholar
• Middleton G, Karp D, Lee E, Cush J. Wegener's granulomatosis presenting as lower back pain with prostatitis and ureteral obstruction. J Rheumatol 1994; 21: 566–569
   PubMed Web of Science ®Google Scholar
• Gross WL, Reinhold-Keller E. ANCA-associated vasculititdes (Wegener's granulomatosis, Churg-Strauss-syndrome, microscopic polyangiitis) 1. Pathogenetic and clinical aspects. Z Rheumatol 1995; 54: 279–290
   PubMed Web of Science ®Google Scholar
• Watts RA, Joliffe VA, Carruthers DM. Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangutis. Arthritis Rheum 1996; 39: 1208–1212
   PubMed Web of Science ®Google Scholar
• Stegeman CA, Tervaert JWC, Jong PE, Kallenberg CGM. for the Dutch cotrimoxazole Wegener study group: Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996; 335: 16–20
   PubMed Web of Science ®Google Scholar
• Nowack R, Birds R, van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 1996; 349: 774
   Web of Science ®Google Scholar
• Andrassy K, Erb A, Koderisch J. Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy, and renal outcome. Clin Nephrol 1991; 35: 139–147
   PubMed Web of Science ®Google Scholar